E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder Cancer
about
Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical TherapyPrediction of Bacillus Calmette-Guerin Response in Patients with Bladder Cancer after Transurethral Resection of Bladder Tumor by Using Genetic Variation Based on Genomic StudiesIntegrative Genomic Analyses Yield Cell-Cycle Regulatory Programs with Prognostic Value
P2860
E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder Cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
E2F4 Program Is Predictive of ...... apy Efficacy in Bladder Cancer
@ast
E2F4 Program Is Predictive of ...... apy Efficacy in Bladder Cancer
@en
type
label
E2F4 Program Is Predictive of ...... apy Efficacy in Bladder Cancer
@ast
E2F4 Program Is Predictive of ...... apy Efficacy in Bladder Cancer
@en
prefLabel
E2F4 Program Is Predictive of ...... apy Efficacy in Bladder Cancer
@ast
E2F4 Program Is Predictive of ...... apy Efficacy in Bladder Cancer
@en
P2860
P1476
E2F4 Program Is Predictive of ...... apy Efficacy in Bladder Cancer
@en
P2093
Chao Cheng
Frederick S Varn
P2860
P304
P356
10.1158/1541-7786.MCR-15-0120
P577
2015-06-01T00:00:00Z